K Scholar, Alexandra Sims, MD, MPH, FAAP in the Division of General and Community Pediatrics, Cincinnati Children’s Hospital was recently named one of the National Minority Quality Forum’s (NMQF) 2022 40 Under 40 Leaders in Minority Health. These young leaders are working to eliminate health inequities and improve outcomes across the country and are considered to be leading the charge to better patient outcomes and building sustainable healthy communities.

Dr. Arun Jose (photo courtesy of University of Cincinnati College of Medicine)

CCTST K Scholar, Arun Jose, MD, MS, Director of Pulmonary Hypertension, Cincinnati VA Medical Center, Assistant Professor, University of Cincinnati Division of Pulmonary, Critical Care, and Sleep Medicine, published an article on a pilot study focusing on unique gut microbiota in pulmonary arterial hypertension (PAH) in the Journal of Pulmonary Circulation on February 11, 2022.

Pulmonary Arterial Hypertension (PAH) is a progressive, ultimately fatal cardiopulmonary disease associated with a number of physiologic changes, which is believed to result in imbalances in the intestinal microbiota. To date, comprehensive investigational analysis of the intestinal microbiota in human subjects is still limited. To address this, Dr. Jose and his team performed a pilot study of the intestinal microbiome in 20 PAH and 20 non-PAH healthy control subjects, recruited from a single center, with each PAH subject recruited simultaneously with a cohabitating non-PAH control subject. Shotgun metagenomic sequencing was used to analyze the microbiome profiles. There were no differences between PAH and non-PAH subjects across several measures of microbial abundance and diversity (Alpha Diversity, Beta Diversity, F/B ratio). The relative abundance of Lachnospiraceae bacterium GAM79 was lower in PAH stool samples as compared to non-PAH control subject’ stool. There was no strong or reproducible association between PAH disease severity and global microbial abundance, but several bacterial species (a relative abundance of Anaerostipes Rhamnosivorans and a relative deficiency of Amedibacterium Intestinale, Ruminococcus bicirculans, and Ruminococcus albus species were associated with disease severity (most proximal right heart catheterization hemodynamics and six minute walk test distance) in PAH subjects. Our results support further investigation into the presence, significance, and potential physiologic effects of a PAH-specific intestinal microbiome.

Publication link: A unique gut microbiota signature in pulmonary arterial hypertension (PAH): a pilot study - Jose - - Pulmonary Circulation - Wiley Online Library

The Journal of Clinical and Translational Science (JCTS) has released a Call for Manuscripts on Adaptive Capacity & Preparedness.  We encourage you to submit publications.  

Additionally, the journal is seeking Peer Reviewers for seven upcoming manuscripts that will be focused on work from the Adaptive Capacity & Preparedness of CTSA Hubs Workgroup. The manuscripts address the following CTSA goals:

• Training/Cultivating the Translational Workforce;

• Engaging Communities in Translational Research;

• Integrating Special & Underserved Populations into Translational Research;

• Improving Quality and Efficiency of Translational Research;

• Use Informatics to Advance Translational Science;

• Providing Translational Science Leadership and Administration, and

• Overview of the E-scan of AC&P across those goals/areas

Peer Reviewing for JCTS is a great opportunity to contribute to understanding and strengthening of the collective capacity and preparedness to advance health research and science (including clinical translational science).  If you, or anyone you know, is interested in being a reviewer, please email Jareen Meinzen-Derr.

Dr. Shuchi Gulati (photo courtesy of University of Cincinnati College of Medicine)

K Scholar, Shuchi Gulati, MD, Division of Hematology and Oncology at the University of Cincinnati will be presenting her research as a poster and an oral presentation at the upcoming American Society of Clinical Oncology (ASCO)’s Genitourinary Cancers Symposium in San Francisco, in February 2022. The poster entitled “Complimentary transcriptomic-metallomic analysis identifies risk of relapse for clear-cell renal cell carcinoma (ccRCC) patients” highlights the work she has done over the last year as a KL2 scholar, where her team identifies transcriptomic signatures and complimentary metallomic biomarkers to identify patients at risk of relapse after surgery. This work will expand further into identifying a biomarker of poor prognosis in kidney cancer, a space where biomarkers are currently non-existent; thus further lending opportunities to identify therapeutic targets as a next step.

In addition, as part of the Precision Oncology Alliance within CARIS Life Sciences, Dr. Gulati’s team will be presenting an oral presentation entitled “Molecular alterations across sites of metastasis in patients with renal cell carcinoma (RCC)”. This work is based on identifying unique transcriptomic and genomic signatures at various sites of metastasis in kidney cancer. She is one of the lead authors on this abstract and through this work will continue her effort to identify biomarkers in kidney cancer, the focus of her KL2 work.

Dr. Arun Jose (photo courtesy of University of Cincinnati College of Medicine)

CCTST K Scholar, Arun Jose, MD, MS, Director of Pulmonary Hypertension, Cincinnati VA Medical Center, Assistant Professor, University of Cincinnati Division of Pulmonary, Critical Care, and Sleep Medicine, published review article on the management of Portopulmonary Hypertension in the Journal of Liver Transplantation on January 19, 2022.

Dr. Jose explains that portopulmonary Hypertension (PoPH) is a rare type of disease affecting the blood vessels connecting the heart to the lungs, that occurs exclusively in people with underlying liver disease. Until recently, much was unclear regarding the best treatment options for these high-risk patients, how PoPH is related to other pulmonary vascular diseases unique to liver disease, and how liver transplantation affects PoPH. This timely review article addresses several of these questions, incorporating recently published scientific research to provide a comprehensive update on the current management of this complex, multi-organ disease.

To read the publication, click here.

The Community Engagement Core Speaker Series took place on December 7 & 14, 2021 via Zoom, with a focus on housing as a driver of health outcomes.  In addition to the keynote address, “Racism as the Driver of Housing and Health Inequities” by speaker, Kamillah Wood, MD, MPH, FAAP, the event recognized the 2021 CCTST Community Awardees (see below). Notably, this year, the CCTST Community Health Advocate Award was renamed in memory of Dr. Anita Brentley.

On December 14th, the CEC hosted a panel discussion featuring Ruth Ann Norton from Green & Healthy Homes Initiative, as well as local speakers Nina Creech (People Working Cooperatively) and Dr. Nick Newman, DO (CCHMC/UC) about research and initiatives addressing the housing safety and access in our local community.  To watch the panel discussion, click here.

Awardees:

• Practice-Based Research Awardees:
  UC Internal Medicine-Pediatric Clinic, Hoxworth Center in partnership with UC Department of Family & Community Medicine Research Division

• Academic-Community Research Partnership Awardees:

  • The Christ Hospital-University of Cincinnati Family Medicine Residency Program (TCHUCFM) in partnership with Walnut Hills Redevelopment Foundation (WHRF), The Walnut Hills Community Partnership Advisory Board, & Equitas Health

  • Domestic Violence Enhanced Response Team (DVERT): A partnership with Women Helping Women, University of Cincinnati School of Criminal Justice, and the Cincinnati Police Department

• Academic-Community Partnership Student Awardees:
  University of Cincinnati, Graduate Students: Aalap Bommaraju, MPH; Stef Murawsky, MA; Zoe Muzyczka, MPH; and Juliana Madzia in partnership with the Transgender Advocacy Council (TAC)

• Integrating Special Populations Awardees:
  Ilka Riddle, PhD & Kara Ayers, PhD - The University of Cincinnati Center for Excellence in Developmental Disabilities

• Dr. Anita L. Brentley Community Health Advocate Awardees

  • Jennifer Foster; Community Health Advocate, Avondale

  • Bryan Wright; Executive Director, Cincinnati Compass

Story released by the University of Cincinnati Dean’s List Weekly Newsletter. Story features CCTST K Scholar, Silvi Shah, MD.

Dr. Silvi Shah (photo courtesy of University of Cincinnati College of Medicine)

Women who receive a kidney transplant have low rates of contraceptive use, according to new research from the College of Medicine. The study, published in the Journal of Nephrology, finds an overall contraceptive use rate of 9.5% among women with kidney transplant in the United States.

“Although kidney failure adversely impacts fertility, there is a return of reproductive function following a kidney transplant, and conception is common. History of kidney transplant increases the risk of adverse pregnancy outcomes, including pre-eclampsia, gestational hypertension, low birth weight babies and preterm births,” says Silvi Shah, MD, associate professor in the Division of Nephrology and Hypertension, Department of Internal Medicine, and lead author of the study. “Unplanned pregnancies occur in women with kidney transplant. It is of paramount importance that pregnancies in this high-risk population are planned and underlines the importance of counseling women about family planning and the impact of pregnancy on kidney transplant, and the impact of kidney transplant on maternal and fetal outcomes.”

The study evaluated 13,150 women of childbearing age for each calendar year women with kidney transplantation between Jan. 1, 2005 and Dec. 31, 2013, who were aged 15 to 44 years with Medicare as the primary payer and linked data from the United Network for Organ Sharing, for up to three entire years after the date of transplantation. Overall, the rate of contraceptive use was 9.5%. The mean age at study entry was 29±7 years for women with any contraceptive use. The contraceptive use was highest among women aged 15 to 24 years (14.6%) and lowest among women aged 40 to 44 years (4.1%). The study showed that younger age, Native American and black race/ethnicity, and glomerular filtration rate < 60 ml/min/1.73 m2 were associated with a higher likelihood of contraceptive use and second- and third-year post-transplant were associated with a lower likelihood of contraceptive use. Interestingly, the socioeconomic status and donor type did not impact the likelihood of contraceptive use. 

Shah says the study is unique in that it addresses a comprehensive group of all women with a history of kidney transplants of all racial and ethnic groups in the United States to better understand the incidence of contraceptive use and factors associated with it. The study further took into account patients with complete Medicare coverage, thus avoiding the potential shortfalls of registries dependent on voluntary reporting or patient recall. This study shows for the first time that contraceptive rates in women with kidney transplant remain low in the United States. 

“We were not able to account for use of natural methods or use of condoms by men in our study, which remains a limitation. However, our results highlight that contraceptive use among women with kidney transplants is low,” says Shah. “The low rate of contraceptive use among women with kidney transplants may be attributed to lack of awareness about return of fertility and inadequate counseling regarding contraception to prevent unplanned pregnancies. Therefore, we need to include contraceptive counselling for women with kidney transplants in routine clinical care. Additionally, the present study emphasizes the importance of formulating policies that promote awareness of reproductive health and contraception among women with kidney transplants.”

Assisting her in the research were Annette Christianson, research associate, Department of Environmental Health, Shalini Bumb, MD, assistant professor, Division of Nephrology and Hypertension, and Prasoon Verma, MD, assistant professor, Department of Pediatrics. Shah is supported by the National Institutes of Health K23 career development award, under award number 1K23HL151816-01A1 and intramural funds.

Story released by the University of Cincinnati Dean’s List Weekly Newsletter. Story features CCTST K Scholar, Silvi Shah, MD.

The CCTST remains steadfast in our committed to diversity, equity, and inclusion (DEI) in clinical and translational research.  Leaders from the Biostatistics, Epidemiology, & Research Design Core and Integration Across the Lifespan core have initiated a seminar series titled “Methods of Race and Racism in Research.”  As part of this series, Dr. Darshali Vyas, M.D. from Massachusetts General Hospital and Harvard Medical School will be joining us on December 8th to discuss the use of race in clinical algorithms.  Reach out to Dr. Katherine Bowers at Katherine.bowers@cchmc.org if you are interested in participating in the seminar series.  See the Community Engagement Core Section for information about Dr. Kamillah Wood, former White House Fellow under the Obama Administration, and as she kicks off the Speaker series for the year.  Finally, every CCTST core has identified SMART goals towards DEI initiatives and we will be implementing them throughout the CCTST.  We are excited as we continue moving forward in this important work.

Dr. Arun Jose (photo courtesy of University of Cincinnati College of Medicine)

K Scholar Arun Jose, MD, MS, in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Cincinnati recently had an article accepted in Respiratory Medicine titled "Predictors of outcomes following liver transplant in hepatopulmonary syndrome: An OPTN database analysis". Hepatopulmonary Syndrome (HPS) is a type of lung disease affecting those with underlying liver disease, and can increase the risks associated with liver transplantation. His team studied national transplant records from the UNOS/OPTN database, clarifying the relationship between HPS disease severity and outcomes following liver transplant. This work will help identify high-risk HPS patients who may require additional resources to successfully undergo lifesaving liver transplantation, and sheds further light on the relationship between lung disease and liver disease, the focus of Dr. Jose's KL2 work.

Publication link: https://pubmed.ncbi.nlm.nih.gov/34784562/

This course provides an overview of the Science of Team Science (SciTS) for investigators who are (or will be) working in transdisciplinary teams. In addition to examining the theoretical and research literature on the dynamics of teams, the course will include an examination of the construction and maintenance of high functioning teams. Tools and exercises for assessing and improving team skills will provide hands-on experiences for learners. The course will include discussions about institutional barriers to working in teams and strategies for overcoming these and other challenges faced by translational researchers navigating in a team-based environment.

Time and Location:

Tuesdays, Spring Semester
January 10 - April 22, 2022
Online, 10am - 12pm

Course Instructor:

Jack Kues, PhD, Professor Emeritus
Director of the Center for Improvement Science
Associate Dean for Research Evaluation, UC COM

Registration:

BE-7040, 51411, 2 credits
Register at catalyst.uc.edu
Regular UC tuition rates apply

Registration Questions:

Contact Rachel Meyer: meyer2rh@uc.edu

CCTST K Scholar, Natalja Stanski, MD, Division of Critical Care Medicine at Cincinnati Children’s Hospital, was selected to be junior faculty at the Pediatric Acute Disease (Dialysis) Quality Initiative (pADQI) meeting held on November 11 – 14, 2021. This will be an international expert consensus meeting focused on drafting summary guidelines for pediatric AKI management and research. To learn more about the pADQI meeting, click here.

Jareen Meinzen-Derr, PhD, CCTST Co-Director and Director of the CCTST Biostatistics, Epidemiology and Research Design Program (BERD), has been invited by the Association for Clinical and Translational Science (ACTS) to serve on its newly formed Diversity Equity and Inclusion Committee.

The committee will develop strategies to address diversity, equity, and inclusion (DEI) across all ACTS activities as well identify key metrics on how to measure DEI within the association.

Dr. Meinzen-Derr will serve on the committee for two years.

Jareen Meinzen-Derr, PhD

Pat Ryan, PhD

Stacey Gomes, MS

Pat Ryan, PhD, Director of the CCTST Translational Workforce Development Core and Stacey Gomes, MS from the CCTST Community Engagement Core have been accepted to participate in the CLIC Cohorts for Change – Anti-Racism Workshop Series. 

This series promotes structural and administrative anti-racism efforts within Clinical Translational Science Award (CTSA) hubs by engaging small groups of CTSA members from different hubs in a six-month (October 2021 – March 2022), facilitated anti-racism cohort-based workshop series. The series combines synchronous and asynchronous learning opportunities and peer-group learning to facilitate short and long-term change, as well as encouraging ongoing organizational reflection and change at participating hubs.

Story released by the University of Cincinnati Dean’s List Weekly Newsletter. Story features CCTST K Scholar Graduate, Moises Huaman, MD.

Moises Huaman, MD, associate professor in the Department of Internal Medicine, Division of Infectious Diseases, University of Cincinnati and 2020 KL2 Program Graduate, will be one of three researchers for a virtual panel discussion “A Conversation with Latinx Researchers,” from 2:00-3:00p.m. on Thursday, October 14, 2021.  Register for “A Conversation with Latinx Researchers”. 

The webinar will be hosted by the New Investigators Working Group and the Latinx Caucus of the Legacy Project in observance of the National Latinx HIV/AIDS Awareness Day (Oct. 15). Featuring Latinx researchers working in academia and conducting HIV research in the United States and Canada, participants will learn about the professional trajectory and career path of investigators from the United States, Venezuela and Peru.

In addition to Dr. Huaman, panelists include Brandon Brown, PhD, associate professor in the Department of Social Medicine, Population and Public Health, University of California, Riverside School of Medicine, and Amaya Perez-Brumer, PhD, assistant professor in the Division of Social and Behavioral Health Science, University of Toronto.

Dr. Huaman also serves as medical director for the Hamilton County Tuberculosis Control Program and has experience conducting tuberculosis and HIV studies locally and internationally. His research focuses on the interplay between tuberculosis, HIV and cardio-metabolic diseases. He is a former Scholar of the AIDS Clinical Trials Group (ACTG) Minority HIV Investigator Mentoring Program and CTSA KL2 Program.

Story released by the University of Cincinnati Dean’s List Weekly Newsletter. Story features CCTST K Scholar Graduate, Moises Huaman, MD.

On September 22, 2021, the CCTST co-sponsored a COVID-19 Vaccine event for Cincinnati Public School (CPS) teens with CCHMC Community Relations, CPS, Cincinnati Health Department, and the Center for Closing the Health Gap. It was very well attended, over 140 participants, which included approximately 9 professionals and 20 student panelists. Teen attendees had some great questions and wrote ideas on ways to reach others in their age range. We had 92 teens complete surveys and will be analyzing the data over the next couple of weeks to evaluate the style and effectiveness of the program, as well as explore students’ willingness to get vaccinated.

Cincinnati’s Channel 9 released a story on the event: https://www.wcpo.com/news/coronavirus/covid-vaccine/cincinnati-childrens-town-hall-addressed-teen-vaccine-concerns.

The CCTST also nominated two staff members for the CLIC Cohorts for Change – Anti-Racism Workshop Series: Pat Ryan, PhD from our Translational Workforce Development Core and Stacey Gomes, MS from our Community Engagement Core.  This series promotes structural and administrative anti-racism efforts within Clinical Translational Science Award (CTSA) hubs by engaging small groups of CTSA members from different hubs in a six-month, facilitated anti-racism cohort-based workshop series. The series combines synchronous and asynchronous learning opportunities and peer-group learning to facilitate short and long-term change, as well as encouraging ongoing organizational reflection and change at participating hubs. 

Date and time flexible! Schedule a 2-hour time slot in October or November

The workshop is designed for teams of 2-4 individuals that have a healthcare challenge. The workshop will help address your challenge using design thinking methodologies.

Design Thinking Partnership:

Cincinnati Children's Hospital has partnered with the Live Well Collaborative to develop a workshop that introduces healthcare teams to design-thinking concepts and methods, and how they can be used to develop innovative, patient-centered, and feasible solutions for healthcare challenges.

Workshops:

Upon completion of the workshop participants will be able to:

1. Apply design-thinking methods to reframe current healthcare challenges to identify creative solutions. You will have a chance to interact with other teams facing healthcare challenges, as well as a multidisciplinary team of designers who can provide expertise and insights as you work to frame and develop innovative solutions.

2. Recognize patterns and opportunities that can add new perspectives to your work.

3. Outline feasible next steps, frame process, identify expertise, and scope funding.

Team Expectations:

1. The session educates participants on the basics of design and how to use design methodologies. Attendees are expected to participate in the use of design tools to help frame and develop an innovative approach to solving their challenge.

2. Identify the current state of the challenge their team is facing. This challenge should be a current issue the team is facing that needs to be addressed.

3. You will participate in the workshop as a small or core team (2-4 recommended). The team should consist of content experts as well as any others you think are important in implementing a healthcare solution (e.g. research coordinators, health care providers such as physicians, nurses, social workers, etc).

4. Be prepared to discuss inhibitors and enablers (barriers and facilitators) to the challenge.

5. Identify milestones that have to be achieved to address the challenge.

6. Identify a time-frame for solution implementation and how success will be measured (teams will work on this during the workshop sessions).

Registration & Questions:

Contact Linda Dunseath: ldunseath@livewellcollaborative.org

Our KL2 Research Scholars Program recently published a manuscript on the development, implementation, and short-term outcomes of the KL2 Visiting Scholars Program that exists between the Clinical and Translational Science Award hubs at the University of Cincinnati, University of Kentucky, and the University of Indiana. 

The KL2 Visiting Scholars Program was developed to promote collaborative cross-CTSA training, leverage academic strengths at host CTSAs, and support the career development of participating scholars through experiential training and the development of new partnerships.  Since 2016, 12 scholars have completed the program, with 6 scheduled to complete it in 2021.  Post-visit surveys (n = 12) indicate that all scholars reported the program was valuable to career development, 11 reported benefit for research development, and 11 reported expansion of collaborative networks. Outcomes surveys (n = 11) revealed subsequent scholar interaction with host institution faculty for 10 scholars, 2 collaborative grant submissions (1 funded), 2 planned grant submissions, 1 published collaborative manuscript, and 3 planned manuscript/abstract submissions.  The Visiting Scholars Program is a cost- and time-efficient program that leverages the academic strengths of CTSAs. The program also enhanced KL2 scholar training by expanding their professional portfolio, promoting research development, and expanding collaborative networks. 

Reference: Journal of Clinical and Translational Science. 2020. 5(1):e67. Visiting Scholars Program to enhance career development among early-career KL2 investigators in Clinical and Translational Science: Implications from a quality improvement assessment. Sheri L Robb, Thomas H Kelly, Victoria L King, Jason T Blackard, Patricia C McGuire

Dr. Arun Jose (photo courtesy of University of Cincinnati College of Medicine)

CCTST KL2 Scholar, Arun Jose, MD, MS, Division of Pulmonary, Critical Care, Sleep Medicine, University of Cincinnati, recently published research on Portopulmonary hypertension (PoPH) from his KL2 Project in the journal, Liver Transplant.  (PoPH) is a type of cardiovascular disease that affects the blood vessels connecting the heart to the lungs in people with underlying liver disease, and can complicate a potentially lifesaving liver transplantation procedure. To investigate the association between PoPH and outcomes following transplantation, Dr. Jose and colleagues studied liver transplantation records from over 62,000 patients through the national United States UNOS/OPTN database. He found that the severity of PoPH predicted death after liver transplantation, at a much lower level than expected, and that PoPH was associated with an increased risk of graft failure following transplant. The new questions raised by this work regarding the complex interplay between PoPH disease severity and liver transplantation, and the underlying mechanisms and biomarkers that drive PoPH disease pathogenesis, are the current focus of Dr. Jose's KL2 work. 

Publication link: https://pubmed.ncbi.nlm.nih.gov/33964116/
Editorial by some experts in the field: https://pubmed.ncbi.nlm.nih.gov/34392597/

This year’s Bioethics, Citizen Science and Human Subject Protection Conference was an entirely virtual conference held from September 8 - 10, 2021.  The conference was a tremendous success, with 475 registrants from 29 U.S. states, and 4 countries (Belgium, Canada, Saudi Arabia, United States). The keynote speaker was Dr. Ross McKinney, Bioethicist and Chief Scientific Officer at the Association of American Medical Colleges, who spoke on “Trust, Privacy, and Your Next-Door Neighbor the Citizen Scientist.” The conference focused on ethical, regulatory, and human subjects protections issues present in the evolving field of citizen science.  This year’s conference was particularly special because it was dedicated to the late Dr. Jim Heubi who, through his CCTST leadership, served as an ardent supporter of our Bioethics conference on our campus since its inception in 2008.

Community Advocacy, Partnership and Research Awards: Call for Nominations Due: October 8, 2021

The Center for Clinical and Translational Science and Training (CCTST) at the University of Cincinnati (UC), Cincinnati Children’s Hospital Medical Center (CCHMC), and the Cincinnati Veterans Affairs Medical Center (VAMC) are requesting nominations for community advocacy, partnership and research awards. These awards have been established to honor excellence in leadership, collaboration, and health promotion in the Greater Cincinnati/Northern Kentucky region.

Eligibility: Nominations should include information about how the nominee meets the qualifying characteristics outlined below. Self-nominations for these awards accepted. Recommendation letters accepted (not required).

Deadline:  Award nomination forms must be submitted via email or fax by October 8, 2021. Winners and nominators will be notified in early November. 

Award Types:

• CCTST Community Health Advocate Award

• CCTST Academic-Community Research Partnership Award

• CCTST Academic-Community Partnership Student Award

• CCTST Practice-Based Research Award

• CCTST Integrating Special Populations Award

To download the Call for Nominations and learn more details about the award types, click here.

We are excited to share that the CCTST Community Engagement Core (CEC) is being honored by local non-profit, People Working Cooperatively (PWC), with the “Friends of PWC Award”!

This award is given each year to a person or organization that has been a particularly important partner to PWC by helping us further our mission. The award ceremony will be held on October 21, 2021.

Aaron Grant, Senior Project Manager at PWC, shares, “Since my first week as a CLI participant in 2017, [the CCTST] has helped us by providing training, grant opportunities, technical support and perhaps most importantly, expanded our network into health care and academic groups, which have led to further research and program partnerships with Children’s Hospital, UC Health, the VA, the UC College of Medicine, and others. We have also learned a tremendous amount by serving on the CEC advisory boards. In fact, much of the innovative health-focused work we’re doing with our housing programs would not have been possible without the support, resources and connections that have come through our relationship with the CCTST.”

Congratulations to Lori Crosby, Monica Mitchell, Stacey Gomes, Kendal Lindsey, and the rest of our CEC team, for this honor.